Amy E Lovett-Racke Selected Research

ublituximab

1/2021	A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
1/2019	B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy E Lovett-Racke Research Topics

Disease

33	Multiple Sclerosis 01/2023 - 01/2002
17	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2024 - 01/2002
7	Inflammation (Inflammations) 01/2022 - 01/2010
6	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 05/2004
5	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 03/2004
3	Relapsing-Remitting Multiple Sclerosis 02/2011 - 01/2010
2	Disease Progression 08/2011 - 02/2007
1	Transverse Myelitis (Necrotizing Myelitis) 01/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2015
1	Neoplasms (Cancer) 03/2014
1	Persistent Infection 03/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2011
1	Lymphoma (Lymphomas) 12/2011
1	Hyperlipidemias (Hyperlipidemia) 12/2011
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2011
1	Contusions 12/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2011
1	Encephalomyelitis (Myeloencephalitis) 01/2010
1	Nervous System Diseases (Neurological Disorders) 09/2008
1	Mumps 09/2006
1	Central Nervous System Diseases (CNS Diseases) 12/2005
1	Hypertriglyceridemia 05/2004
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 05/2003

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 04/2024 - 12/2010
5	CytokinesIBA 05/2015 - 01/2002
5	AntigensIBA 08/2014 - 11/2004
4	Small Interfering RNA (siRNA)IBA 04/2010 - 11/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2011 - 03/2006
3	Glatiramer Acetate (Copaxone)FDA Link 02/2011 - 03/2002
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2018
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 09/2008
2	ublituximabIBA 01/2021 - 01/2019
2	Interleukin-23 (Interleukin 23)IBA 01/2017 - 10/2011
2	Dimethyl FumarateIBA 08/2014 - 08/2012
2	Myelin-Oligodendrocyte GlycoproteinIBA 03/2014 - 10/2010
2	Gemfibrozil (Lopid)FDA LinkGeneric 12/2011 - 05/2004
2	OligonucleotidesIBA 12/2011 - 11/2004
2	Fenofibrate (CiL)FDA LinkGeneric 12/2011 - 05/2004
2	Interleukin-17 (Interleukin 17)IBA 02/2011 - 02/2007
2	Myelin Basic ProteinIBA 10/2010 - 02/2007
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2010 - 03/2006
2	PPAR alphaIBA 04/2009 - 05/2004
2	LigandsIBA 03/2004 - 03/2002
2	PPAR-gamma AgonistsIBA 03/2004 - 03/2002
2	PPAR gammaIBA 03/2004 - 03/2002
2	Protein Tyrosine PhosphatasesIBA 05/2003 - 05/2002
2	Tyrosine (L-Tyrosine)FDA Link 05/2002 - 03/2002
1	AntibodiesIBA 01/2023
1	Oligoclonal BandsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017
1	Interleukin-7 (Interleukin 7)IBA 12/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2016
1	Flavin Mononucleotide (FMN)IBA 12/2015
1	Natalizumab (Tysabri)FDA Link 08/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 08/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2014
1	Dextrans (Dextran)FDA Link 03/2014
1	Peptides (Polypeptides)IBA 03/2014
1	mouse MIRN29 microRNAIBA 08/2012
1	4-Aminopyridine (4 Aminopyridine)FDA Link 08/2012
1	Interleukin-4 (Interleukin 4)IBA 12/2011
1	Neuroprotective AgentsIBA 12/2011
1	Interleukin-12 (IL 12)IBA 10/2011
1	FumaratesIBA 10/2011
1	Interleukin-10 (Interleukin 10)IBA 10/2011
1	Proteins (Proteins, Gene)FDA Link 04/2010
1	SteroidsIBA 01/2010
1	Hormones (Hormone)IBA 01/2010
1	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2006
1	Antisense OligonucleotidesIBA 11/2004
1	ciprofibrateIBA 05/2004
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2004
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2002
1	Lysine (L-Lysine)FDA Link 03/2002
1	Glutamic Acid (Glutamate)FDA Link 03/2002
1	Alanine (L-Alanine)FDA Link 03/2002
1	RetinoidsIBA 01/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2002

Therapy/Procedure

10	Therapeutics 10/2021 - 03/2002
1	Oral Administration 05/2004